San Diego, CA, United States of America

Sophie Lefebvre

USPTO Granted Patents = 2 


Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Sophie Lefebvre

Introduction

Sophie Lefebvre is an accomplished inventor based in San Diego, California. She has made significant contributions to the field of pharmaceuticals, holding two patents that showcase her innovative spirit and dedication to advancing medical science.

Latest Patents

Sophie Lefebvre's latest patents include "Bicyclic Compounds and Compositions" and "Bis-Aromatic Alkanols." The first patent relates to bicyclic derivatives, detailing a process for their production, their uses, and pharmaceutical compositions containing them. This invention provides a novel class of compounds that are useful in the treatment or prevention of diseases mediated by lymphocyte interactions, particularly those associated with EDG/S1P receptor-mediated signal transduction. The second patent focuses on biphenylyl derivatives, outlining processes for their production, their uses, and pharmaceutical compositions containing them. The compounds described in this patent are based on a specific chemical formula, with substituents defined in the documentation.

Career Highlights

Sophie is currently associated with Irm LLC, where she continues to push the boundaries of pharmaceutical innovation. Her work has garnered attention for its potential impact on treating various medical conditions.

Collaborations

Sophie collaborates with talented individuals such as Shifeng Pan and Nathanael Schiander Gray, contributing to a dynamic and innovative work environment.

Conclusion

Sophie Lefebvre exemplifies the spirit of innovation in the pharmaceutical industry. Her patents reflect her commitment to developing new solutions for complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…